MENLO PARK, Californie - AN2 Therapeutics Inc. (NASDAQ:ANTX) a annoncé son intention de lancer une étude clinique de phase 2 sur l’epetraborole oral chez les adultes atteints de polyglobulie de Vaquez ...
Enter a world of splendor and romance, of eye-popping excess, of glitz, grandeur and glory! A world where Bohemians and aristocrats rub elbows and revel in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results